Raphael Pharmaceutical Inc.
RAPH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $20 | $50 | $19 | $40 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $2 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $41 | $4 | $9 |
| Total Curr. Assets | $28 | $91 | $25 | $49 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $30 | $93 | $27 | $51 |
| Liabilities | – | – | – | – |
| Payables | $473 | $379 | $125 | $537 |
| Short-Term Debt | $41 | $41 | $41 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $564 | $407 | $603 | $130 |
| Total Curr. Liab. | $1,078 | $827 | $769 | $667 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,078 | $827 | $769 | $667 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $196 | $196 | $187 | $187 |
| Retained Earnings | -$9,640 | -$9,318 | -$8,889 | -$8,434 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $8,396 | $8,388 | $7,960 | $7,631 |
| Total Equity | -$1,048 | -$734 | -$742 | -$616 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $30 | $93 | $27 | $51 |
| Net Debt | $21 | -$9 | $22 | -$40 |